U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06964243) titled 'Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain' on April 17.
Brief Summary: Neuropathic pain is frequent and drugs relieves only 50% of the patients. Repetitive transcranial magnetic stimulation (rTMS) at high frequency (HF, usually 10Hz) applied on the primary motor cortex (M1) is an effective treatment of neuropathic pain. For the treatment of chronic pain, the 'classical' HF-rTMS protocol (CHF-rTMS) include one daily session for one or two weeks as an induction phase of treatment followed by a weekly session to produce analgesic effects. However, another type of protocol is based on a more spaced repetition...